
Invizius
Developer of a complementary-regulating therapy platform designed to mitigate harmful immune responses in extracorporeal medical procedures. The company offers a novel priming protein that coats dialy...
Valuation
$0
Share Price
N/A
Total Raised
$19M
Last Round
N/A